|4Mar 21, 5:55 PM ET

Kamocsay Jennifer 4

4 · Akoya Biosciences, Inc. · Filed Mar 21, 2023

Insider Transaction Report

Form 4
Period: 2023-03-20
Kamocsay Jennifer
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2023-03-20+37,50037,500 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-20+75,00075,000 total
    Exercise: $7.60Exp: 2033-03-20Common Stock (75,000 underlying)
Footnotes (3)
  • [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on March 1, 2024, and annually thereafter until fully vested.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
  • [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on February 27, 2024 with the remainder vesting in 36 equal monthly installments beginning on March 27, 2024.

Documents

1 file
  • 4
    tm239789-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT